Recent-onset ecstasy use: Association with deviant behaviors and psychiatric comorbidity

Experimental and Clinical Psychopharmacology

Volumn 14, Issue 3, 2006, Pages 275-286

  Martins, Silvia S ^a   Mazzotti, Guido ^a   Chilcoat, Howard D ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Deviant behaviors; Ecstasy use; Psychiatric comorbidity

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CANNABIS; COCAINE; DIAMORPHINE; ILLICIT DRUG; PSYCHEDELIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BEHAVIOR DISORDER; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DRUG USE; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PANIC; QUESTIONNAIRE; THEFT;

ADOLESCENT; ADULT; CHILD; DATA COLLECTION; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; MALE; MENTAL DISORDERS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; SUBSTANCE-RELATED DISORDERS;

EID: 33747603470     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.14.3.275     Document Type: Article

References (74)

1. Baggott, M., Heifets, B., Jones, R. T., Mendelson, J., Sferios, E., & Zhender, J. (2000). Chemical analysis of ecstasy pills. Journal of the American Medical Association, 284, 2190.
2. Buchert, R., Thomasius, R., Nebeling, B., Petersen, K., Obrocki, J., Jenicke, L., et al. (2003). Long-term effects of "ecstasy" use on serotonin transporters of the brain investigated by PET. Journal of Nuclear Medicine, 44, 375-384.
3. Buchert, R., Thomasius, R., Wilke, F., Petersen, K., Nebeling, B., Obrocki, J., et al. (2004). A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters. American Journal of Psychiatry, 161, 1181-1189.
4. Butler, G. K., & Montgomery, A. M. (2004). Impulsivity, risk taking and recreational "ecstasy" (MDMA) use. Drug and Alcohol Dependence, 76, 55-62.
5. Carlson, R. G., Wang, J., Falck, R. S., & Siegal, H. A. (2005). Drug use practices among MDMA/ecstasy users in Ohio: A latent class analysis. Drug and Alcohol Dependence, 79, 167-179.
6. Chen, C. Y., & Anthony, J. C. (2003). Possible age-associated bias in reporting of clinical features of drug dependence: Epidemiological evidence on adolescent-onset marijuana use. Addiction, 98, 71-82.
7. Chen, C. Y., & Anthony, J. C. (2004). Epidemiological estimates of risk in the process of becoming dependent upon cocaine: Cocaine hydrochloride powder versus crack cocaine. Psychopharmacology, 172, 78-86.
8. Chromy, J., Davis, T., Packer, L., & Gfroerer, J. (2002). Mode effects on substance use measures: Comparison of 1999 CAI and PAPI measures. In L. Gfroerer, E. Eyerman, & J. Chromy (Eds.), Redesigning an ongoing national household survey: Methodological issues (DHHS Publication No. SMA 03-3768, pp. 135-159). Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies.
9. Commins, D. L., Vosmer, G., Virus, R., Woolverton, W., Schuster, C., & Seiden, L. (1987). Biochemical and histological evidence that methylenedioxymethamphetamine (MDMA) is toxic to neurons in the rat brain. The Journal of Pharmacology and Experimental Therapeutics, 241, 338-345.
10. Daumann, J., Hensen, G., Thimm, B., Rezk, M., Till, B., & Gouzoulis-Mayfranck, E. (2004). Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: Further evidence from a combined cross-sectional/longitudinal investigation. Psychopharmacology, 173, 398-404.
11. Degenhardt, L., Barker, B., & Topp, L. (2004). Patterns of ecstasy use in Australia: Findings from a national household survey. Addiction, 99, 187-195.
12. Degenhardt, L., Copeland, J., & Dillon, P. (2005). Recent trends in the use of "club drugs": An Australian review. Substance Use and Misuse, 40, 1241-1256.
13. Dughiero, G., Schifano, F., & Forza, G. (2001). Personality dimensions and psychopathological profiles of Ecstasy users. Human Psychopharmacology, 16, 635-639.
14. Farrell, A. D., Danish, S. J., & Howard, C. W. (1992). Relationship between drug use and other problem behaviors in urban adolescents. Journal of Consulting and Clinical Psychology, 60, 705-712.
15. Farrell, A. D., Kung, E. M., White, K. S., & Valois, R. F. (2000). The structure of self-reported aggression, drug use, and delinquent behaviors during early adolescence. Journal of Clinical Child Psychology, 29, 282-292.
16. Fendrich, M., & Johnson, T. P. (2005). Race/ethnicity differences in the validity of self-reported drug use: Results from a household survey. Journal of Urban Health, 82(2 Suppl. 3), 67-81.
17. Fendrich, M., Johnson, T. P., Wislar, J. S., & Hubbel, A. (2004). Drug test feasibility in a general population household survey. Drug and Alcohol Dependence, 73, 237-250.
18. Fendrich, M., Johnson, T. P., Wislar, J. S., Hubbel, A., & Spiehel, V. (2004). The utility of drug testing in epidemiological research: Results from a general population survey. Addiction, 99, 197-208.
19. Fergusson, D. M., & Horwood, J. L. (2000). Does cannabis use encourage other forms of illicit drug use? Addiction, 5, 505-520.
20. Freese, T. E., Miotto, K., & Reback, C. J. (2002). The effects and consequences of selected club drugs. Journal of Substance Abuse Treatment, 23, 151-160.
21. Gerra, G., Zaimovic, A., Ferri, M., Zambelli, U., Timpano, M., Neri, E., et al. (2000). Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans. Biological Psychiatry, 47, 127-136.
22. Gerra, G., Zaimovic, A., Giucastro, G., Maestri, M., Monica, C., Sartori, R., et al. (1998). Serotonergic function after (±)3, 4-methylene-dioxymethamphetamine ("Ecstasy") in humans. International Clinical Psychopharmacology, 13, 1-9.
23. Goldsamt, L. A., O'Brien, J., Clatts, M. C., & McGuire, L. S. (2005). The relationship between club drug use and other drug use: A survey of New York City middle school students. Substance Use and Misuse, 40, 1539-1555.
24. Gross, S. R., Barrett, S. P., Shestowsky, J. S., & Pihl, R. O. (2002). Ecstasy and drug consumption patterns: A Canadian rave population study. Canadian Journal of Psychiatry, 47, 546-551.
25. Halpern, J. H., Pope, H. G., Jr., Sherwood, A. R., Barry, S., Hudson, J. I., & Yurgelen-Todd, D. (2004). Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to drugs. Drug and Alcohol Dependence, 75, 35-47.
26. Hammersley, R., Ditton, J., Smith, I., & Short, E. (1999). Patterns of ecstasy use by drug users. British Journal of Criminology, 39, 625-647.
27. Harris, D. S., Baggott, M., Mendelson, J. H., Mendelson, J. E., & Jones, R. T. (2002). Subjective and hormonal effects of 3,4- methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology, 162, 396-405.
28. Hendrickson, J. C., & Gerstein, D. R. (2005). Criminal involvement among young male ecstasy users. Substance Use and Misuse, 40, 1557-1575.
29. Jessor, R. (1987). Problem-behavior theory, psychosocial development, and adolescent problem drinking. British Journal of Addiction, 82, 331-342.
30. Jessor, R., & Jessor, S. L. (1977). Problem behavior and psychosocial development. New York: Academic Press.
31. Johnson, T., & Fendrich, M. (2005). Modeling sources of selfreport bias in a survey of drug use epidemiology. Annals of Epidemiology, 15, 381-389.
32. Johnston, L. D., O'Malley, P. M., & Bachman, J. G. (2001a). Monitoring the future: National survey results on drug use, 1975-2000. Volume I: Secondary school students. Bethesda, MD: National Institute on Drug Abuse.
33. Johnston, L. D., O'Malley, P. M., & Bachman, J. G. (2001b). Monitoring the future: National survey results on drug use, 1975-2000. Volume II: College students and young adults ages 19-40. Bethesda, MD: National Institute on Drug Abuse.
34. Johnston, L. D., O'Malley, P. M., & Bachman, J. G. (2002). Monitoring the future: National results on adolescent drug use. Overview of key findings. Bethesda, MD: National Institute on Drug Abuse.
35. Johnston, L. D., O'Malley, P. M., & Bachman, J. G. (2003). Ecstasy use falls for second year in a row, overall news teen drug use drops. Retrieved July 10, 2005, from www .monitoringthefuture.org
36. Johnston, L. D., O'Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2004). Monitoring the future: National survey results on drug use, 1975-2003. Volume I: Secondary school students (NIH Publication No. 04-5507). Bethesda, MD: National Institute on Drug Abuse.
37. Joy, J. E., Watson, S. J., Jr., & Benson, J. A., Jr. (1999). Marijuana and medicine: Assessing the science base. Washington, DC: National Academy Press.
38. Kandel, D. B. (2002). Examining the gateway hypothesis: Stages and pathways of drug involvement. In D. B. Kandel (Ed.), Stages and pathways of drug involvement: Examining the gateway hypothesis (pp. 3-18). Cambridge, England: Cambridge University Press.
39. Kandel, D. B. (2003). Does marijuana use cause the use of other drugs? Journal of the American Medical Association, 289, 482-483.
40. Lieb, R., Schuetz, C. G., Pfister, H., von Sydow, K., & Wittchen, H. (2002). Mental disorders in ecstasy users: A prospective-longitudinal investigation. Drug and Alcohol Dependence, 68, 195-207.
41. Liechti, M. E., Gamma, A., & Vollenweider, F. X. (2001). Gender differences in the subjective effects of MDMA. Psychopharmacology, 154, 161-168.
42. Lynskey, M. T., Fergusson, D. M., & Horwood, J. L. (1998). The origins of the correlations between tobacco, alcohol, and cannabis use during adolescence. Journal of Child Psychology and Psychiatry, 39, 995-1005.
43. Lynskey, M. T., Heath, A. C., Bucholz, K. K., Slutske, W. S., Madden, P. A. F., Nelson, E. C., et al. (2003). Escalation of drug use in early-onset cannabis users versus co-twin controls. Journal of the American Medical Association, 289, 427-433.
44. Martins, S. S., Mazzotti, G., & Chilcoat, H. D. (2005). Trends in ecstasy use in the United States from 1995 to 2001: Comparison with marijuana users and association with other drug use. Experimental and Clinical Psychopharmacology, 13, 244-252.
45. Maxwell, J. C. (2005). Party drugs: Properties, prevalence, patterns, and problems. Substance Use and Misuse, 40, 1203-1240.
46. McCaughan, J. A., Carlson, R. G., Falck, R. S., & Siegal, H. A. (2005). From "Candy Kids" to "Chemi-Kids": A typology of young adults who attend raves in the midwestern United States. Substance Use and Misuse, 40, 1503-1523.
47. Milich, R., Lynam, D., Zimmerman, R., Logan, T. K., Martin, C., Leukefeld, C., et al. (2000). Differences in young adult psychopathology among drug abstainers, experimenters, and frequent users. Journal of Substance Abuse, 11, 69-88.
48. Molliver, M. E., Berger, U. V., Mamounas, L. A., Molliver, D. C., O'Hearn, E. G., & Wilson, M. A. (1990). Neurotoxicity of MDMA and related compounds: Anatomic studies. Annals of the New York Academy of Science, 600, 649-661.
49. Morgan, M. J. (1998). Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology, 19, 252-264.
50. Morland, J. (2000). Toxicity of drug abuse-amphetamine designer drugs (ecstasy): Mental effects and consequences of single dose use. Toxicology Letters, 112-113, 147-152.
51. Morral, A. R., McCaffrey, D. F., & Chien, S. (2003). Measurement of adolescent drug use. Journal of Psychoactive Drugs, 35, 301-309.
52. Morral, A. R., McCaffrey, D. F., & Paddock, S. M. (2002). Reassessing the marijuana gateway effect. Addiction, 97, 1493-1504.
53. Ompad, D. C., Galea, S., Fuller, C. M., Edwards, V., & Vlahov, D. (2005). Ecstasy use among Hispanic and black substance users in New York City. Substance Use and Misuse, 40, 1399-1407.
54. Osgood, D. W., Johnston, L. D., O'Malley, P. M., & Bachman, J. G. (1988). The generality of deviance in late adolescence and early adulthood. American Sociological Review, 53, 80-92.
55. Pape, H., & Rossow, I. (2004). Ordinary people with "normal" lives? A longitudinal study of ecstasy and other drug use among Norwegian youth. Journal of Drug Issues, 34, 389-418.
56. Parrott, A. C., Buchanan, T., Scholey, A. B., Heffernan, T., Ling, J., & Rodgers, J. (2002). Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users. Human Psychopharmacology, 17, 309-312.
57. Parrott, A. C., Milani, R. M., Parmar, R., & Turner, J. D. (2001). Recreational ecstasy/MDMA and other drug users from the UK and Italy: Psychiatric symptoms and psychobiological problems. Psychopharmacology, 159, 77-82.
58. Parrott, A. C., Sisk, E., & Turner, J. J. (2000). Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users. Drug and Alcohol Dependence, 60, 105-110.
59. Pedersen, W., & Skrondal, A. (1999). Ecstasy and new patterns of drug use: A normal population study. Addiction, 94, 1695-1706.
60. Quednow, B. B., Kuhn, K. U., Hoppe, C., Westheide, J., Maier, W., Daum, I., et al. (2006). Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("Ecstasy"). Psychopharmacology (Berl), Jan 20, 1-14 [Epub ahead of print]. DOI: 10.1007/s00213- 005-0256-4.
61. Scholey, A. B., Parrott, A. C., Buchanan, T., Heffernan, T. M., Ling, J., & Rodgers, J. (2004). Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/ MDMA users: A WWW study. Addictive Behaviors, 29, 743-752.
62. Schütz, C. G., Chilcoat, H. D., & Anthony, J. C. (1994). The association between sniffing inhalants and injecting drugs. Comprehensive Psychiatry, 35, 99-105.
63. StataCorp. (2003). Stata Statistical software: Release 8.0. College Station, TX: Author.
64. Strote, J., Lee, J. E., & Wechsler, H. (2002). Increasing MDMA use among college students: Results of a national survey. Journal of Adolescent Health, 30, 64-72.
65. Substance Abuse and Mental Health Services Administration. (2002a). Results from the 2001 National Household Survey on Drug Abuse: Volume I. Summary of national findings (NHSDA Series H-17, DHHS Publication No. SMA 02-3758). Rockville, MD: Author, Office of Applied Studies.
66. Substance Abuse and Mental Health Services Administration. (2002b). Results from the 2001 National Household Survey on Drug Abuse: Volume II. Technical appendices and selected data tables (NHSDA Series H-18, DHHS Publication No. SMA 02-3759). Rockville, MD: Author, Office of Applied Studies.
67. Sumnall, H. R., & Cole, J. C. (2005). Self-reported depressive symptomatology in community samples of polysubstance misusers who report ecstasy use: A meta-analysis. Journal of Psychopharmacology, 19, 84-92.
68. Tancer, M., & Johansen, C. E. (2003). Reinforcing, subjective, and physiological effects of MDMA in humans: A comparison with d-amphetamine and mCPP. Drug and Alcohol Dependence, 72, 33-44.
69. Thomasius, R., Petersen, K., Buchert, R., Andresen, B., Zapletalova, P., Wartberg, L., et al. (2003). Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology, 167, 85-96.
70. Thomasius, R., Petersen, K., Zapletalova, P., Wartberg, L., Zeichner, D., & Schmoldt, A. (2005). Mental disorders in current and former heavy ecstasy (MDMA) users. Addiction, 100, 1310-1319.
71. Topp, L., Hando, J., Dillon, P., Roche, A., & Solowij, N. (1999). Ecstasy use in Australia: Patterns of use and associated harm. Drug and Alcohol Dependence, 55, 105-115.
72. Turner, C. F., Ku, L., Rogers, S. M., Lindberg, L. D., Pleck, J. H., & Sonestein, F. L. (1998, May 8). Adolescent sexual behavior, drug use, and violence: Increased reporting with computer survey technology. Science, 280, 867-873.
73. Verheyden, S. L., Henry, J. A., & Curran, H. V. (2003). Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users. Human Psychopharmacology, 18, 507-517.
74. Yacoubian, G. S., Jr., Arria, A. M., Fost, E., & Wish, E. D. (2002). Estimating the prevalence of Ecstasy use among juvenile offenders. Journal of Psychoactive Drugs, 34, 209-213.